Analysts: Disney’s Infinity Sales May Surpass Expectations and 3 Other Research Notes to Browse
Disney (NYSE:DIS): Stifel raised its estimates on Disney based on an acceleration in the company’s share buyback plan and better-than-expected sales of the company’s Infinity video game. The firm keeps a Buy rating on the stock.
Teva Pharmaceutical (NYSE:TEVA): JPMorgan downgraded Teva to Neutral from Overweight on its belief that the company’s recovery will be gradual. The firm lowered its price target for shares to $43 from $45.
Micron (NASDAQ:MU): Bernstein believes Micron is benefiting from slowing bit growth per wafer, which is leading to an undersupply of flash memory products and higher prices. Also set to boost Micron are its Elpida acquisition and a fire at a competitor’s plant, according to the firm, which keeps an Outperform rating on Micron.
Visa (NYSE:V): Stifel is more upbeat on both Visa and MasterCard (NYSE:MA) after MasterCard reported that spending growth was accelerating. The firm found MasterCard’s commentary on Durbin encouraging. Stifel prefers Visa over MasterCard because Visa is trading at a significant discount to MasterCard. It keeps a Buy rating on Visa and identifies the stock as a top pick.